Maria C. De Angelis

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A more-Comers populAtion trEated with an ultrathin struts polimer-free Sirolimus stent: an Italian post-maRketing study (the CAESAR registry).

A more-Comers populAtion trEated with an ultrathin struts polimer-free Sirolimus stent: an Italian post-maRketing study (the CAESAR registry).

Journal: Frontiers in cardiovascular medicine

Published: October 22, 2023

Drug Coated Balloon in the Treatment of De Novo Coronary Artery Disease: A Narrative Review.

Drug Coated Balloon in the Treatment of De Novo Coronary Artery Disease: A Narrative Review.

Journal: Journal of clinical medicine

Published: April 03, 2023

ANMCO Position paper: Cardiovascular disease in women - prevention, diagnosis, treatment and organization of care

ANMCO Position paper: Cardiovascular disease in women - prevention, diagnosis, treatment and organization of care

Journal: Giornale italiano di cardiologia (2006)

Published: September 28, 2022

ImpaCt of an Optimal Implantation Strategy on Absorb Long-Term Outcomes: The CIAO Registry.

ImpaCt of an Optimal Implantation Strategy on Absorb Long-Term Outcomes: The CIAO Registry.

Journal: Cardiovascular revascularization medicine : including molecular interventions

Published: February 23, 2020

Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes.

Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes.

Journal: The American journal of cardiology

Published: January 14, 2018

Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study).

Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study).

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: September 14, 2017

Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation?

Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation?

Journal: Journal of thoracic disease

Published: September 13, 2017

First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.

First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.

Journal: Coronary artery disease

Published: June 03, 2017

Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry).

Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry).

Journal: International journal of cardiology

Published: January 29, 2017

An imbalance between protective and detrimental molecular pathways is associated with right ventricular dysfunction in congenital heart diseases with outflow obstruction.

An imbalance between protective and detrimental molecular pathways is associated with right ventricular dysfunction in congenital heart diseases with outflow obstruction.

Journal: International journal of cardiology

Published: January 12, 2014

β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapy.

β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapy.

Journal: Circulation

Published: August 24, 2013

Percutaneous treatment of a aorto-caval fistula in a old high risk patient.

Percutaneous treatment of a aorto-caval fistula in a old high risk patient.

Journal: BMC surgery

Published: November 24, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026